Literature DB >> 9932614

Stroke risk factors and stroke prevention.

M S Elkind1, R L Sacco.   

Abstract

Stroke is the third leading cause of death and the leading cause of chronic disability in the United States. In the past several decades, case series, case-control studies, and prospective cohort studies have successfully identified nonmodifiable risk markers for stroke, such as age, gender, race, ethnicity, heredity and several well-established modifiable risk factors for ischemic stroke. Hypertension, atrial fibrillation, other cardiac diseases, hyperlipidemia, diabetes, cigarette smoking, physical inactivity, carotid stenosis, and transient ischemic attack (TIA) are all potentially treatable conditions that predispose to stroke. Research on other putative stroke risk factors-including antiphospholipid antibodies, elevated homocysteine, alcohol, inflammation, and infection-is ongoing. Controlled trials have shown that stroke risk can be reduced by blood-pressure control, lipid-lowering agents, surgery for carotid stenosis, warfarin for atrial fibrillation, and antiplatelet agents. It is hoped that an improved understanding of stroke risk factors will reduce the future burden of stroke.

Entities:  

Mesh:

Year:  1998        PMID: 9932614     DOI: 10.1055/s-2008-1040896

Source DB:  PubMed          Journal:  Semin Neurol        ISSN: 0271-8235            Impact factor:   3.420


  18 in total

1.  Homocysteine and folate deficiency sensitize oligodendrocytes to the cell death-promoting effects of a presenilin-1 mutation and amyloid beta-peptide.

Authors:  Kirk J Pak; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

2.  Neurophysiological studies of chronic cerebral ischemia.

Authors:  N G Starosel'tseva
Journal:  Neurosci Behav Physiol       Date:  2009-07

3.  Homocysteine elicits a DNA damage response in neurons that promotes apoptosis and hypersensitivity to excitotoxicity.

Authors:  I I Kruman; C Culmsee; S L Chan; Y Kruman; Z Guo; L Penix; M P Mattson
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

4.  Stroke risk among Chinese immigrants in New York City.

Authors:  Jing Fang; Sun Hoo Foo; Cora Fung; Judith Wylie-Rosett; Michael H Alderman
Journal:  J Immigr Minor Health       Date:  2006-10

5.  Folic acid deficiency and homocysteine impair DNA repair in hippocampal neurons and sensitize them to amyloid toxicity in experimental models of Alzheimer's disease.

Authors:  Inna I Kruman; T S Kumaravel; Althaf Lohani; Ward A Pedersen; Roy G Cutler; Yuri Kruman; Norman Haughey; Jaewon Lee; Michele Evans; Mark P Mattson
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

6.  Presenilin-1 mutation increases neuronal vulnerability to focal ischemia in vivo and to hypoxia and glucose deprivation in cell culture: involvement of perturbed calcium homeostasis.

Authors:  M P Mattson; H Zhu; J Yu; M S Kindy
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

Review 7.  Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits.

Authors:  M P Mattson; S L Chan
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 8.  Migraine and the risk of stroke: an updated meta-analysis of prospective cohort studies.

Authors:  Xianming Hu; Yingchun Zhou; Hongyang Zhao; Cheng Peng
Journal:  Neurol Sci       Date:  2016-10-26       Impact factor: 3.307

9.  Association between the MMP-9-1562 C>T polymorphism and the risk of stroke: a meta-analysis.

Authors:  Zhen-Zhen Fan; Zhao-Ming Ge; Hong-Bin Cai; Zhi-Yan Liu; Pei Liu; Hao-Yue Wang
Journal:  Mol Biol Rep       Date:  2014-07-11       Impact factor: 2.316

Review 10.  Ischemic stroke, aortic dissection, and thrombolytic therapy--the importance of basic clinical skills.

Authors:  Moti Grupper; Ayelet Eran; Alla Shifrin
Journal:  J Gen Intern Med       Date:  2007-07-10       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.